Compositions, suitable for oral administration, comprising a triazolo [4, 5-d]pyrimidin derivate

Details for Australian Patent Application No. 2007288541 (hide)

Owner AstraZeneca AB

Inventors Banks, Simon

Agent Davies Collison Cave

Pub. Number AU-B-2007288541

PCT Pub. Number WO2008/024045

Priority 60/823,083 21.08.06 US

Filing date 20 August 2007

Wipo publication date 28 February 2008

Acceptance publication date 25 August 2011

International Classifications

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

Event Publications

5 March 2009 PCT application entered the National Phase

  PCT publication WO2008/024045 Priority application(s): WO2008/024045

25 August 2011 Application Accepted

  Published as AU-B-2007288541

22 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007288544-Combined pharmaceutical formulation with controlled-release comprising Dihydropyridine calcium channel blockers and HMG-CoA reductase inhibitors

2007288523-Antioxidant for preventing and treating diseases caused by oxidative stress